Hematocrit was not validated as a surrogate end point for survival among epoetin-treated hemodialysis patients

Dennis J. Cotter, Kevin Stefanik, Yi Zhang, Mae Thamer, Daniel Scharfstein, James Kaufman

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Hematocrit was not validated as a surrogate end point for survival among epoetin-treated hemodialysis patients'. Together they form a unique fingerprint.

Medicine & Life Sciences